TUGUZBAEVA, G.,
YUE, E.,
CHEN, X.,
HE, L.,
LI, X.,
JU, J.,
QIN, Y.,
PAVLOV, V.,
LU, Y.,
JIA, W.,
BAI, Y.,
NIU, Y.,
YANG, B (2019) -dissociating
therapeutic agent in vitro. Firstly, we found marked enrichment of αv integrin in collectively invading
AKHMADIEV, N.S.,
AKHMETOVA, V.R.,
IBRAGIMOV, A.G.,
GALIMOVA, A.M.,
GALIMOVA, R.A.,
AGLETDINOV, E.F.,
KATAEV, V.A.,
KHAIRULLINA, V.R. (2019) providing a basis for the
therapeutic effects of five-membered palladacycles (as mixture of stereoisomers
LATYPOVA, G.M.,
BYCHENKOVA, M.A.,
KATAYEV, V.A.,
PERFILOVA, V.N.,
TYURENKOV, I.N.,
MOKROUSOV, I.S.,
PROKOFIEV, I.I.,
SALIKHOV, SH.M.,
IKSANOVA, G.R. (2019) treatment. These facts necessitate a search for new pharmacological
agents for the CHF correction. Herbal
FENG, C.,
GONG, R.,
ZHENG, Q.Y.,
YANG, G.G.,
HE, M.Y.,
LEI, H.,
LI, X.D.,
ZHANG, L.,
XU, Z.H.,
LIU, S.Z.,
YU, M.X.,
MA, T.S.,
GAO, M.Q.,
BAMBA, D.,
IDIYATULLINA, E.T.,
ZAGIDULLIN, N.SH.,
PAVLOV, V.N.,
XU, C.Q.,
YUAN, Y.,
YANG, L. (2019) Arsenic trioxide (ATO) has been well recognized as an anti-tumor
agent for various human cancers
Paar, V.,
Jirak, P.,
Larbig, R.,
Zagidullin, N.S.,
Brandt, M.C.,
Lichtenauer, M.,
Hoppe, U.C.,
Motloch, L.J. (2019) . We highlight the
therapeutic potential of gene therapy as a novel and innovative approach for future
LIU, Z.,
ZHANG, R.,
CHEN, X.,
YAO, P.,
YAN, T.,
LIU, W.,
YAO, J.,
ZHAO, S.,
SOKHATSKII, A.,
GAREEV, I. (2019) , to act as
therapeutic targets, and to identify potential small-molecule compounds for treating ICH